Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond | British Journal of Cancer
PTK 7 Is a Transforming Gene and Prognostic Marker for Breast Cancer and Nodal Metastasis Involvement | PLOS ONE
JCI Insight - DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma
Prognostic markers
Clinical Relevance of Prognostic and Predictive Molecular Markers in Gliomas | SpringerLink
Prognostic and predictive factors for lung cancer | European Respiratory Society
Clinical and molecular prognostic markers of survival after surgery for gastric cancer: tumor-node-metastasis staging system and beyond. | Semantic Scholar
Prognostic immunohistologic markers in human tumors: why are so few used in clinical practice? | Laboratory Investigation
LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia | Haematologica
Alterations in ALK gene emerge as prognostic marker for neuroblastoma survival
Evaluating the Platelet Distribution Width-to-Plateletcrit Ratio as a Prognostic Marker for Patients With Breast Cancer | Anticancer Research
Cellular prognostic markers in hepatitis-related hepatocellular carcinoma | Infectious Agents and Cancer | Full Text
MiR-130b Is a Prognostic Marker and Inhibits Cell Proliferation and Invasion in Pancreatic Cancer through Targeting STAT3 | PLOS ONE
Predictive and Prognostic Markers in Adults With Acute Myeloid Leukemia: A Single-Institution Experience - ScienceDirect
IJMS | Free Full-Text | A2AR as a Prognostic Marker and a Potential Immunotherapy Target in Human Glioma
CEA - Prognostic Marker for Breast Cancer: GOHEL, Dr HARDIK R: 9781794454927: Amazon.com: Books
Personalising cancer medicine with prognostic markers - eBioMedicine
Molecular predictive and prognostic markers in colon cancer. | Semantic Scholar
Pathogenic steps and corresponding prognostic markers. | Download Scientific Diagram
High neutrophil to lymphocyte ratio as a prognostic marker in COVID-19 patients - Clinical Nutrition ESPEN
Genes | Free Full-Text | FERMT1 Is a Prognostic Marker Involved in Immune Infiltration of Pancreatic Adenocarcinoma Correlating with m6A Modification and Necroptosis
Characterization of prognostic markers to predict COVID-19 severity
Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples - eBioMedicine
